Award recordCONTRACT

PROGENICS PHARMACEUTICALS INC

PIID 36C26125N0096· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6505 · DRUGS AND BIOLOGICALS· FY2025· $1,502,419 net obligations· UEI YLYKVRPCTCR3· MA

Description

OPTION YEAR ONE

First action · last action
2024-10-01 · 2025-12-11
Transactions
4
First transaction's obligation
$1,084,616
Base + all options value (sum of deltas)
$1,502,419
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C26123A0014
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 4 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1,539,315$0Base award · 2024-10-01 · this action $1,084,616 · running total $1,084,616Modification P00001 · 2025-07-24 · this action $335,611 · running total $1,420,227Modification P00002 · 2025-09-24 · this action $119,088 · running total $1,539,315Modification P00003 · 2025-12-11 · this action -$36,896 · running total $1,502,419
  • Base2024-10-01+$1,084,616= $1,084,616
  • Mod P000012025-07-24+$335,611= $1,420,227
  • Mod P000022025-09-24+$119,088= $1,539,315
  • Mod P000032025-12-11-$36,896= $1,502,419
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2024-10-01+$1,084,616$1,084,616OPTION YEAR ONE
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2025-07-24+$335,611$1,420,227OPTION YEAR ONE
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2025-09-24+$119,088$1,539,315OPTION YEAR ONE
Mod P00003· CLOSE OUT2025-12-11−$36,896$1,502,419OPTION YEAR ONE

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI YLYKVRPCTCR3)

AwardOffice · PSC / listingNet obligationsFY
36C24626N0890246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS$1,212,530FY2026
36C24626A0027246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C26226F0313262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$180,436FY2026
36C25026N0655250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$721,744FY2026
36C26026F0298260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$469,134FY2026
36C25026N0531250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$559,352FY2026

Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126P1178OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026
36C26126P1102ENVIGO RMS LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$74,586FY2026
36C26126P096110X GENOMICS, INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$34,600FY2026
36C26126P0997SIERRA RADIOPHARMACY LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$247,204FY2026
36C26126P1008OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26125N0096_3600_36C26123A0014_3600 · retrieved 2026-09-26.